Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch domain-containing protein 4 (KLHDC4) is a human protein encoded by the KLHDC4 gene. It is a member of the Kelch-domain superfamily, which is characterized by multiple Kelch motifs that typically mediate protein–protein interactions and cytoskeleton-associated functions. KLHDC4 has been implicated in the suppression of apoptosis and oncogenesis, particularly in nasopharyngeal carcinoma, and is associated with certain neurodegenerative disorders. While it is not a classic receptor, enzyme, or transporter, it acts as a regulatory protein and may serve as a biomarker and potential therapeutic target in cancer[2][3][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch domain-containing protein 4 (KLHDC4).